Case Reports in Pathology

Volume 2013 (2013), Article ID 205692, 6 pages

http://dx.doi.org/10.1155/2013/205692

Case Report

Growth Patterns of Placental and Paraovarian Adrenocortical Heterotopias Are Different

Hua Zhong,¹ Bo Xu,² and Dorota A. Popiolek³

¹Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School and Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA

²Department of Pathology and Laboratory Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA

³Department of Pathology and Laboratory Medicine, New York University School of Medicine, New York, NY 10016, USA

Received 13 September 2013; Accepted 18 October 2013

Academic Editors: Y. Nagashima and Z. Schaff

Copyright © 2013 Hua Zhong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Two cases of adrenocortical heterotopia are reported. One is in a full-term placenta. The other is adjacent to the ovarian hilum of an adult. Both are incidental findings. Despite sharing similar histological and immunological features, they show different growth patterns. The literature is reviewed and adrenocortical heterotopias of different locations are compared. New hypotheses of its histogenesis are discussed.

1. Introduction

Adrenocortical heterotopia is usually an incidental finding in surgical pathology practice. It is often a solitary round micronodule comprising pure adrenocortical tissue with clinically insignificant function. The majority of heterotopic locations are closely related to the bilateral routes of gonadal descent. Distant heterotopia is, however, not uncommon and can be found in many major organ systems including the kidneys [1–3], lungs [4, 5], brain or spinal cord [6, 7], and liver [8–11]. Demographically, adrenocortical heterotopia can be found in men and women, pediatric and adult patients, and fetus or even placenta [12–16]. According to a general review by Dr. Jaffe of New York [17], adrenocortical heterotopia may be present in as many as 50% of postmortems on males of “new born or very young infant” and in 50% of normal rats at sexual maturity in the epididymal region if cautiously searched for. The majority of the heterotopias may become atrophic with maturation of the normal adrenal glands [17]. Herein, two cases of adrenocortical heterotopia are reported. One was within a full-term placenta. The other was embedded in the adipose tissue adjacent to the right ovarian hilum of an adult female patient. Their cytological and immunological features are similar while their architectural patterns are different.

2. Case A

A 30-year-old woman, gravida 3, para 2, had a spontaneous vaginal delivery of a 40-week gestational age male infant. The mother’s medical history was significant for abnormal glucose tolerance and a previous spontaneous abortion. The infant was 3,000 grams and 42 cm long with Apgar scores of 9. The development of the infant was normal at the one-year followup. The placenta received without fixatives was 560 grams and  cm. The umbilical cord with an eccentric placental insertion was grossly normal, and the fetal membranes were unremarkable. The cotyledons were red and complete. The placenta was sectioned at 0.5 cm intervals, and no gross abnormalities were noted on the cut surfaces. Two random full-thickness sections were taken for hematoxylin and eosin stain. Histologically, a 0.2 cm well-circumscribed subchorionic nodule was present and within a thick layer of fibrin-like materials that stimulated a pseudocapsule. A few small villi were embedded within this pseudocapsule. A definite fibrous capsule was not present. The nodule was compacted with oval or round cells intermingling with abundant fine vasculature. The cells had well-defined borders and a low nuclear/cytoplasm ratio. The cytoplasm showed clear spongy appearance that was partly clear and partly contained fine eosinophilic granules. Cells in the periphery appeared to have slightly less amount of eosinophilic granules and were less vascularized. Nuclei were small and frequently binucleated. Immunohistochemical stains were performed with appropriate controls. The cells within the subchorionic microscopic nodule were diffusely positive for inhibin alpha, Melan-A, and cytokeratin Cam5.2. Stains for inhibin alpha and Melan-A were cytoplasmic and granular and weak to moderate in intensity. The Cam5.2 stain was membranous and cytoplasmic and moderate to strong in intensity. All positive cells were diffusely distributed, and no specific patterns were seen. Both histological and immunological findings supported that the solitary nodule was heterotopic immature adrenocortical tissue (Figure 1). The overall growth architecture of the lesion had no pattern and did not appear to resemble either fetal or maturing adrenocortical tissue.

(a)

(b)

(c)

(d)

(e)

(f)

Figure 1: An adrenocortical heterotopia located in subchorionic space described in Case A. (a) Hematoxylin and eosin, ×20. (b) Hematoxylin and eosin, ×40. (c) Hematoxylin and eosin, ×200. (d) Immunohistochemical staining by using a monoclonal antibody against human inhibin alpha, ×100 (insert ×400). (e) Immunohistochemical staining by using a monoclonal antibody against human Melan-A, ×100 (insert ×400). (f) Immunohistochemical staining by using a monoclonal antibody against human Cam5.2, ×100 (insert ×400).

3. Case B

A 56-year-old woman without clinical or laboratory evidence of adrenal dysfunction, gravida 4, para 2, was admitted for bilateral salpingo-oophorectomy due to adnexal masses. Grossly, bilateral multiloculated ovarian cysts were identified, which were diagnosed as serous cystadenomas. During microscopic assessment, a 0.2 cm round nodule was found in the adipose tissue adjacent to the hilum of the right ovary. Histologically, it was encapsulated with a thin layer of fibrous tissue and was composed of cells cytologically similar but not identical to those found in Case A (Table 1). There was a well-demarcated zonation pattern in Case B, showing a discontinued subcapsular layer, a layer of cells with clear spongy cytoplasm, a layer of cells with abundant eosinophilic granular cytoplasm, and a central irregular zone of clear cells mixed with thin-walled small vessels. Immunohistologically, the cells were also focally positive for Calretinin, HMB45, and CD10 in addition to showing immunoreactivity with antibodies against inhibin alpha, Melan-A, and Cam5.2 as in Case A. inhibin alpha was predominately positive in the cells with abundant eosinophilic granular cytoplasm (Figure 2(d)). The Melan-A immunostain was diffusely positive while the staining intensity was stronger in subcapsular cells (Figure 2(e)). The immunostaining pattern of Calretinin was similar to that of inhibin alpha but with both nuclear and cytoplasmic staining, which was predominately positive in the cells with abundant eosinophilic granular cytoplasm (Figure 2(f)). The histological and immunological findings supported that the nodule was heterotopic mature adrenocortical tissue (Figure 2).

Table 1: Clinical and pathological characteristics of reported cases.

Findings
Case A
Case B

Patient
30 yo female
56 yo female

Location
Term placenta, subchorionic
Right ovary, hilar fat

Lesion size
0.2 cm
0.2 cm

Shape
Round nodule
Round nodule

Capsule
Pseudocapsule
Thin fibrous capsule

Zonation pattern
No
Yes

Vasculature
Abundant
Less abundant

Differentiation
Immature
Mature

(a)

(b)

(c)

(d)

(e)

(f)

Figure 2: An adrenocortical heterotopia located adjacent to the ovarian hilum described in Case B. (a) Hematoxylin and eosin, ×20. (b) Hematoxylin and eosin, ×40. (c) Hematoxylin and eosin, ×200. (d) Immunohistochemical staining by using a monoclonal antibody against human inhibin alpha, ×40 (insert ×200). (e) Immunohistochemical staining by using a monoclonal antibody against human Melan-A, ×40 (insert ×200); a different chromogene was used during developing positive signals. (f) Immunohistochemical staining by using a monoclonal antibody against human Calretinin, ×40 (insert ×200).

4. Discussion

The developments of the urogenital and adrenal glands are closely associated. Therefore, accessory or heterotopic adrenal cortical tissue is usually found in the retroperitoneal regions near the adrenal glands, kidneys, or along the descending tracts of the urogenital organs [18, 19]. Less common locations of adrenocortical heterotopia have been reported, such as within renal parenchyma [1–3], inside distant organs [4–11], and in the placenta [12–16]. Nonplacental origin of the heterotopia, including those near the urogenital tract and from distant organs, can be seen in any demographically diverse patient populations, adults, children, fetuses, and in both males and females. The lesion is most commonly found as an incidental finding in pediatric patients during inguinoscrotal operations. The reported incidence ranges from 1.6% to 2.5% in these patients [20–22]. Adrenocortical heterotopia is often solitary. Twin nodules next to each other were reported in the perigonadal location of a fetus [23]. Pure adrenocortical cells are demonstrated in all cases except one in a paratracheal location that was reported to have both cortical and medullary components [4].

Adrenocortical heterotopia in the placenta is uncommon. Only six cases have been reported since Cox et al. described the first case [12–16]. Table 2 summarizes the findings of previously reported cases and the current case. In all cases, the heterotopias are from third trimester or term placentas of child-bearing-age women as incidental findings. Two cases are associated with twin placentas [15, 16]. The lesions are all solitary, ovoid, or round and range from less than 0.1 to 0.4 cm (average, 0.2 cm) in diameter. They can be located within either a stem villus, a subchorionic anchoring villus, or a subchorionic space immediately underneath the roof plate, as in the current case. Based on the description of previous reports and again as shown in the current case, the histological features of the adrenocortical nodules from placental locations are similar and show sheets of ovoid or polygonal cells with prominent cell membranes, clear to eosinophilic granular cytoplasm and rich in tiny vessels. In cytology, these cells appear to be similar to those in the zona fasciculate. However, the overall configuration is patternless, and the typical zonation pattern of the adrenal cortex is not seen. It is interesting to note that the typical zonation pattern is also not seen in lesions within solid organs (Table 3), including intrarenal locations [1–3] or within distant organs [4–11]. For instance, the zonation pattern was not shown in an intrahepatic adrenocortical heterotopia in a 38-week neonate, though irregular islands of definitive zone type cortical cells were present [8]. In contrast, the zonation pattern is histologically and immunohistologically seen in Case B, in which the lesion was in close proximity to the ovary. This growth pattern that typically shows three layers of adrenocortical cells is usually seen in other reported cases found close proximity to urogenital organs. In the fetus, the zonation pattern is demarcated by orderly, arranged cells with definitive and fetal zones, reported in a heterotopic adrenocortical nodule of a perigonadal location [23]. Immunohistochemically, the zonation pattern is seen in Case B that is composed of well-differentiated mature adrenocortical tissue, while this is not shown in Case A, which is composed of poorly differentiated and patternless fetal-type-like adrenocortical tissue but lacks zonation growth pattern or a definitive zone. One may question if these cells are functional. A direct answer is yes, since the lesional cells express dehydroepiandrosterone sulfate (DHEA-S) [14] and inhibin alpha. But no evidence has thus far indicated that the heterotopic adrenal gland located in the placenta can undergo a hyperfunctional or neoplastic change. In contrast, heterotopic adrenocortical nodules from nonplacental locations are evident by a variety of pathological changes that lead to hyperfunction, such as hyperplasia, adenoma, or even carcinoma (Table 3). The differences in histology, immunohistochemistry, and functional potential indicate the cellular origins of heterotopic adrenocortical nodules among different locations could be different.

Table 2: Summary of basic clinical and pathological features of adrenocortical heterotopia in the placenta.

%
Maternal age
Gestational age
Placenta (gram)
Lesion size (cm)
Location
Reference

1
27 (g2p1)
36
?
?
Stem villus
[12]

2
25 (g3p2)
?
350
0.2
Stem villus
[13]

3
26 (g2p1)
37
540
0.4
Stem villus
[14]

4
30 (g2p1)
34 (twin)
405/340
<0.1
Stem villus
[15]

5
39 (g9p7)
38
350
<0.1
Stem villus
[15]

6
29 (g1p1)
? (twin)
280/285
0.2
Subchorionic
[16]

7
30 (g3p2)
40
560
0.2
Subchorionic
Current case

Table 3: Comparison of basic pathological features of adrenocortical heterotopia of different locations.

Vicinity of urogenital organs
Intrarenal or within distant organs
Placental

Zonation pattern
Yes
No
No

Medullar component
Not reported
Reported in one case [4]
Not reported

Shape
Round
Round or irregular
Round

Size
Variable
Up to 1.5 cm
~0.2 cm

Number of lesions
Two lesions reported in one fetus [22]
Solitary
Solitary

Hyperfunctional or neoplastic
Reported
Reported
Not reported

References
[17, 18, 22]
[1–11]
[12–16]

Abnormally located adrenal tissue was once classified into ectopic (accessory) type and heterotopic type [4]. The former, also known as adrenocortical rest, usually denoted those found in the vicinity of the adrenal glands and along the routes of gonadal descent. The latter was named because they were located within other organs. In the most recent surgical pathology textbook by Dr. Rosai [24], adrenocortical heterotopia is used as a general term that includes all abnormally located adrenocortical tissue. Indeed, the terminology is not important in such cases since they are basically similar in the pathological manifestation and the histogenesis is largely unclear. Regarding the histogenesis of these lesions, one hypothesis is that cells forming adrenocortical heterotopia derive from the adrenal primordial stage, then migrate to adjacent or distant organs. The cells of primordial stage in fact function as mobile adrenocortical stem cells. We think that adrenocortical heterotopia may also form locally. This may be true, especially for those in the placental location that can originate from the placental parenchyma or fetal blood. This hypothesis not only explains why adrenocortical tissue is present in organs other than the placenta, but also explains why tissues other than adrenocortex can be found in the placenta [25–27]. In particular, recent studies have demonstrated that placental-derived mesenchymal stem cells (PD-MSCs) are multipotent, which allows them to differentiate into different mesodermal lineage cells such as osteocytes, chondrocytes, cardiac muscle, or endothelial cells [28, 29]. In addition, adrenocortical heterotopia may also be related to genetic or epigenetic alterations. Steroidogenic factor Ad4BP/SF-1, encoded by the NR5A1 gene in chromosome 3q11, is critical for early adrenal differentiation [30], and transgenic expression of Ad4BP/SF-1 in fetal adrenal progenitor cells results in adrenocortical heterotopia [31]. The results suggest that any genetic alteration or epigenetic signals that lead to Ad4BP/SF1 activation could facilitate the formation of adrenocortical heterotopia.

In summary, we believe that adrenocortical heterotopia of any location is a result of multifactorial reasons that might have genetic and epigenetic roots. What term should be used in diagnosing an abnormally located adrenocortical tissue is probably not of great concern. For clinical practice, the key issue is to make the correct diagnosis and to understand that the majority of such lesions are clinically insignificant.

Conflict of Interests

The authors declare that they have no conflict of interests.

Acknowledgments

The authors are thankful to Drs. Lorraine Pan and Melissa Yee-Chang for their proofreading and inspiring comments on the initial drafts of the paper.

References

L. Chin, R. I. Brody, P. Morales, and V. H. Black, “Immunocytochemical characterization of intrarenal adrenal tissue,” Urology, vol. 44, no. 3, pp. 429–432, 1994.

D. Baydar and O. Aydin, “Confusing cases: clear cell but not renal cell lesions in kidney,” Pathology International, vol. 58, no. 11, pp. 713–717, 2008.

I. Brčić, T. Leniček, M. Ulamec, M. Tomić, and B. Krušlin, “Intrarenal ectopic adrenal tissue associated with renal angiomyolipoma,” Pathology International, vol. 61, no. 12, pp. 778–780, 2011.

K. Shigematsu, K. Toriyama, K. Kawai, and O. Takahara, “Ectopic adrenal tissue in the thorax: a case report with in situ hybridization and immunohistochemical studies,” Pathology Research and Practice, vol. 203, no. 7, pp. 543–548, 2007.

C. Bozic, “Ectopic fetal adrenal cortex in the lung of a newborn,” Virchows Archiv A, vol. 363, no. 4, pp. 371–374, 1974.

A. Mitchell, B. W. Scheithauer, H. Sasano et al., “Symptomatic intradural adrenal adenoma of the spinal nerve root: report of two cases,” Neurosurgery, vol. 32, no. 4, pp. 658–662, 1993.

K. Makino, R. Kojima, H. Nakamura et al., “Ectopic adrenal cortical adenoma in the spinal region: case report and review of the literature,” Brain Tumor Pathology, vol. 27, no. 2, pp. 121–125, 2010.

M. A. Vestfrid, “Ectopic adrenal cortex in neonatal liver,” Histopathology, vol. 4, no. 6, pp. 669–672, 1980.

K. Arai, H. Muro, M. Suzuki, O. Noriyuki, I. Kazuki, and H. Sasano, “Adrenal rest tumor of the liver: a case report with immunohistochemical investigation of steroidogenesis,” Pathology International, vol. 50, no. 3, pp. 244–248, 2000.

T. Tajima, A. Funakoshi, Y. Ikeda et al., “Nonfunctioning adrenal rest tumor of the liver: radiologic appearance,” Journal of Computer Assisted Tomography, vol. 25, no. 1, pp. 98–101, 2001.

Y. M. Shin, “Hepatic adrenal rest tumor mimicking hepatocellular carcinoma,” The Korean Journal of Hepatology, vol. 16, no. 3, pp. 338–341, 2010.

J. N. Cox and F. Chavrier, “Heterotopic adrenocortical tissue within a placenta,” Placenta, vol. 1, no. 2, pp. 131–133, 1980.

K. Kraft, “Accessory adrenocortical tissue within a placenta,” Zeitschrift fur Geburtshilfe und Perinatologie, vol. 188, no. 4, pp. 191–193, 1984.

C. A. Labarrere, D. Caccamo, M. Telenta, O. Althabe, and R. Gutman, “A nodule of adrenocortical tissue within a human placenta: light microscopic and immunocytochemical findings,” Placenta, vol. 5, no. 2, pp. 139–143, 1984.

F. Qureshi and S. M. Jacques, “Adrenocortical heterotopia in the placenta,” Pediatric Pathology and Laboratory Medicine, vol. 15, no. 1, pp. 51–56, 1995.

M. Guschmann, M. Vogel, and M. Urban, “Adrenal tissue in the placenta: a heterotopia caused by migration and embolism?” Placenta, vol. 21, no. 4, pp. 427–431, 2000.

H. J. Jaffe, “The suprarenal gland,” Archives of Pathology & Laboratory Medicine, vol. 3, pp. 414–453, 1927.

M. Czaplicki, L. Bablok, B. Kuzaka, and Z. Janczewski, “Heterotopic adrenal tissue,” International Urology and Nephrology, vol. 17, no. 2, pp. 177–181, 1985.

M. Pujani, N. K. Madan, M. Choudhury, and M. Rao, “Aberrant adrenal tissue in omentum: an incidental finding on ovarian cystectomy,” Journal of Clinical and Diagnostic Research, vol. 7, pp. 606–607, 2013.

G. Vaos, N. Zavras, and I. Boukouvalea, “Ectopic adrenocortical tissue along the inguinoscrotal path of children,” International Surgery, vol. 91, no. 3, pp. 125–128, 2006.

D. S. Dobanovacki, D. M. Maric, D. L. Maric et al., “Ectopic adrenocortical tissue: an incidental finding during inguinal surgery in children,” Fetal & Pediatric Pathology, vol. 31, no. 1, pp. 32–37, 2013.

S. Ketata, H. Ketata, A. Sahnoun, H. FakhFakh, A. Bahloul, and M. N. Mhiri, “Ectopic adrenal cortex tissue: an incidental finding during inguinoscrotal operations in pediatric patients,” Urologia Internationalis, vol. 81, no. 3, pp. 316–319, 2008.

L. M. Ernst, E. D. Ruchelli, and D. S. Huff, Eds., Color Atlas of Fetal and Neonatal Histology, Springer, New York, NY, USA, 2011.

J. Rosai, Ed., Rosai and Ackerman's Surgical Pathology, vol. 1, Mosby Elsevier, 10th edition, 2011.

M. A. Khalifa, D. J. Gersell, C. H. Hansen, and J. M. Lage, “Hepatic (hepatocellular) adenoma of the placenta: a study of four cases,” International Journal of Gynecological Pathology, vol. 17, no. 3, pp. 241–244, 1998.

Z. Vesoulis and D. Agamanolis, “Benign hepatocellular tumor of the placenta,” American Journal of Surgical Pathology, vol. 22, no. 3, pp. 355–359, 1998.

L. E. Harris and J. E. Wenzl, “Heterotopic pancreatic tissue and intestinal mucosa in the umbilical cord. Report of a case,” The New England Journal of Medicine, vol. 268, pp. 721–722, 1963.

O. Parolini, F. Alviano, G. P. Bagnara et al., “Concise review: isolation and characterization of cells from human term placenta: outcome of the First International Workshop on Placenta Derived Stem Cells,” Stem Cells, vol. 26, no. 2, pp. 300–311, 2008.

G. Brooke, M. Cook, C. Blair et al., “Therapeutic applications of mesenchymal stromal cells,” Seminars in Cell and Developmental Biology, vol. 18, no. 6, pp. 846–858, 2007.

N. A. Hanley, W. E. Rainey, D. I. Wilson, S. G. Ball, and K. L. Parker, “Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation,” Molecular Endocrinology, vol. 15, no. 1, pp. 57–68, 2001.

M. Zubair, S. Oka, K. L. Parker, and K. I. Morohashi, “Transgenic expression of Ad4BP/SF-1 in fetal adrenal progenitor cells leads to ectopic adrenal formation,” Molecular Endocrinology, vol. 23, no. 10, pp. 1657–1667, 2009.